- Healthia (HLA) expects to report a healthy FY22 financial performance following a release of its unaudited report
- The healthcare company is expecting its revenue to be between $195 to $200 million, which is higher than the $140.4 million in FY21
- Earnings before interest, taxes, depreciation and amortisation is expected to be between $30 to $32.5 million, which is around the same as last year’s $30.4 million
- During the year, the company experienced a range of COVID-19 impacts which increased patient appointment cancellations and significant team member absenteeism
- However, over the last several weeks, trading conditions and financial performance has been good and at a level that Healthia believes it can provide this forecast
- Healthia is down 1.91 per cent and trading at $1.54 per share at market close
Healthia (HLA) is expecting to report a healthy FY22 financial performance following a release of its unaudited report.
The healthcare company is expecting its revenue to be between $195 to $200 million, which is higher than the $140.4 million in FY21.
Earnings before interest, taxes, depreciation and amortisation is expected to be between $30 to $32.5 million, which is around the same as last year’s $30.4 million.
During the year, the company experienced a range of COVID-19 impacts which increased patient appointment cancellations and significant team member absenteeism due to illness and isolation.
However, over the last several weeks, trading conditions and financial performance has been good and at a level that Healthia believes it can provide this forecast.
“FY22 has been a significant year for Healthia, during which it positioned itself as one of Australia’s largest providers of allied health services with over 300 allied health businesses across Australia and New Zealand,” the company said.
Earlier this year, the company purchased three new businesses in the health care industry for a total consideration of $1.83 million. The businesses include Restore Movement, Re-Wired Hand Therapy, and the Eye Place.
Over FY23, Healthia said it will continue to grow through strategic acquisitions.
On top of this announcement, the company also agreed to buy hand therapy businesses in Victoria and Queensland. This includes Bay Hand Therapy in Beaumaris, Victoria, and two Sunshine Coast Hand Therapy businesses.
Total acquisition costs is $1.70 million and the businesses are expected to contribute a revenue of $1.58 million to Healthia’s annualised earnings.
On the market, Healthia was down 1.91 per cent and trading at $1.54 per share at market close.